Standard BioTools Gross Margin 2012-2025 | LAB
Current and historical gross margin for Standard BioTools (LAB) over the last 10 years. The current gross profit margin for Standard BioTools as of September 30, 2025 is %.
| Standard BioTools Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $0.17B | $0.08B | 46.71% |
| 2025-06-30 | $0.17B | $0.08B | 47.93% |
| 2025-03-31 | $0.17B | $0.08B | 47.34% |
| 2024-12-31 | $0.17B | $0.08B | 48.28% |
| 2024-09-30 | $0.12B | $0.06B | 50.00% |
| 2024-06-30 | $0.12B | $0.06B | 47.93% |
| 2024-03-31 | $0.13B | $0.06B | 48.82% |
| 2023-12-31 | $0.11B | $0.05B | 47.17% |
| 2023-09-30 | $0.11B | $0.05B | 45.71% |
| 2023-06-30 | $0.11B | $0.05B | 43.40% |
| 2023-03-31 | $0.10B | $0.04B | 37.11% |
| 2022-12-31 | $0.10B | $0.04B | 36.36% |
| 2022-09-30 | $0.11B | $0.05B | 40.91% |
| 2022-06-30 | $0.11B | $0.05B | 44.25% |
| 2022-03-31 | $0.13B | $0.06B | 49.60% |
| 2021-12-31 | $0.13B | $0.07B | 52.67% |
| 2021-09-30 | $0.14B | $0.08B | 54.35% |
| 2021-06-30 | $0.15B | $0.09B | 57.72% |
| 2021-03-31 | $0.14B | $0.09B | 59.03% |
| 2020-12-31 | $0.14B | $0.08B | 58.99% |
| 2020-09-30 | $0.13B | $0.07B | 58.73% |
| 2020-06-30 | $0.11B | $0.06B | 56.25% |
| 2020-03-31 | $0.11B | $0.06B | 55.26% |
| 2019-12-31 | $0.12B | $0.06B | 55.17% |
| 2019-09-30 | $0.12B | $0.07B | 56.03% |
| 2019-06-30 | $0.12B | $0.07B | 56.30% |
| 2019-03-31 | $0.12B | $0.07B | 56.41% |
| 2018-12-31 | $0.11B | $0.06B | 55.36% |
| 2018-09-30 | $0.11B | $0.06B | 52.78% |
| 2018-06-30 | $0.10B | $0.05B | 50.96% |
| 2018-03-31 | $0.10B | $0.05B | 50.00% |
| 2017-12-31 | $0.10B | $0.05B | 50.49% |
| 2017-09-30 | $0.10B | $0.05B | 52.00% |
| 2017-06-30 | $0.10B | $0.05B | 53.61% |
| 2017-03-31 | $0.10B | $0.06B | 55.45% |
| 2016-12-31 | $0.10B | $0.06B | 56.73% |
| 2016-09-30 | $0.11B | $0.06B | 57.27% |
| 2016-06-30 | $0.12B | $0.07B | 58.12% |
| 2016-03-31 | $0.12B | $0.07B | 58.47% |
| 2015-12-31 | $0.12B | $0.07B | 58.62% |
| 2015-09-30 | $0.12B | $0.07B | 60.17% |
| 2015-06-30 | $0.12B | $0.07B | 60.50% |
| 2015-03-31 | $0.12B | $0.07B | 61.86% |
| 2014-12-31 | $0.12B | $0.07B | 63.25% |
| 2014-09-30 | $0.11B | $0.07B | 64.76% |
| 2014-06-30 | $0.09B | $0.06B | 67.74% |
| 2014-03-31 | $0.08B | $0.06B | 70.73% |
| 2013-12-31 | $0.07B | $0.05B | 71.83% |
| 2013-09-30 | $0.07B | $0.05B | 71.21% |
| 2013-06-30 | $0.06B | $0.04B | 70.49% |
| 2013-03-31 | $0.06B | $0.04B | 68.42% |
| 2012-12-31 | $0.05B | $0.04B | 67.92% |
| 2012-09-30 | $0.05B | $0.03B | 68.00% |
| 2012-06-30 | $0.05B | $0.03B | 66.67% |
| 2012-03-31 | $0.05B | $0.03B | 67.39% |
| 2011-12-31 | $0.04B | $0.03B | 68.18% |
| 2011-09-30 | $0.04B | $0.03B | 68.29% |
| 2011-06-30 | $0.04B | $0.03B | 71.05% |
| 2011-03-31 | $0.04B | $0.02B | 68.57% |
| 2010-12-31 | $0.03B | $0.02B | 66.67% |
| 2010-06-30 | $0.02B | $0.01B | 55.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.581B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.549B | 41.11 |
| Tempus AI (TEM) | United States | $11.881B | 0.00 |
| Doximity (DOCS) | United States | $7.738B | 31.86 |
| Hims & Hers Health (HIMS) | United States | $6.936B | 56.43 |
| IRHYTHM HLDGS (IRTC) | United States | $5.335B | 0.00 |
| Hinge Health (HNGE) | United States | $3.276B | 0.00 |
| Heartflow (HTFL) | United States | $2.912B | 0.00 |
| Privia Health (PRVA) | United States | $2.855B | 178.54 |
| 10x Genomics (TXG) | United States | $2.791B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.744B | 45.41 |
| Omnicell (OMCL) | United States | $2.202B | 45.01 |
| Azenta (AZTA) | United States | $1.818B | 74.57 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Enovis (ENOV) | United States | $1.321B | 6.93 |
| Schrodinger (SDGR) | United States | $1.202B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.043B | 0.00 |
| Phreesia (PHR) | United States | $0.948B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.856B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Claritev (CTEV) | United States | $0.471B | 0.00 |
| Evolent Health (EVH) | United States | $0.440B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.353B | 0.00 |
| Carlsmed (CARL) | United States | $0.337B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.335B | 0.00 |
| TruBridge (TBRG) | United States | $0.302B | 13.86 |
| CapsoVision (CV) | United States | $0.292B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.290B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.258B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.176B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.169B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.156B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.092B | 0.00 |
| American Well (AMWL) | United States | $0.075B | 0.00 |
| Pulmonx (LUNG) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.069B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.064B | 0.00 |
| 111 (YI) | China | $0.044B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.039B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.020B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.012B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |